Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous vs Intravenous Palonosetron in Cancer Patients
NCT01046240Phase 2Completed
- Sponsor
- Universidad de Navarra
- Start
- Oct 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Universidad de Navarra. Started Oct 2009; status: completed.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01046240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01046240.